This conjugate has paved the way for developing other peptide/small molecule conjugates for treating diabetes and obesity, such as GLP-1/dexamethasone [10], GLP-1/tesaglitazar [9], and GLP-1/MK-801 [11]. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.